Delivery Order SPE2DB20D3101-SPE2DB25FRCB3
Award Date
2/14/25
Potential Completion Date
2/18/25
Potential Value
$5.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,908.86 firm fixed-price contract is for the supply of Bydureon Bcise 2 mg autoinjectors, a medication used to treat type 2 diabetes. This delivery order is issued under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,029.17 firm fixed-price contract is for the delivery of Bydureon Bcise 2 mg autoinjector 0.85 ml, a medication used to treat type 2 diabetes. The order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,942.86, is for the supply of Bydureon BCISE 2 mg autoinjectors, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of October 13, 2023 and is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $47,211.38, is for the delivery of Bydureon BCISE 2 mg autoinjector 0.85 ml to support federal healthcare programs. The contract has an ultimate completion date of March 12, 2024 and is a firm fixed price delivery order. This award is associated with a larger Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,580.39, is for the supply of Bydureon BCISE 2 mg autoinjector 0.85 ml, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of October 23, 2023 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Bydureon BCISE 2 mg autoinjectors, a medication used for the treatment of type 2 diabetes. The contract has a ceiling value of $4,157.22 and a period of performance through November 7, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation...
This is a delivery order (SPE2DX23FXHWV) awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,028.08 fixed-price contract is for the delivery of 4561970863 Bydureon Bcise 2 mg autoinjector 0.85 mL, which are used to treat type 2 diabetes. This order is part of a larger Indefinite Delivery Contract (IDC), valued at up to $999,999,999, that Amerisourcebergen holds with the DLA Troop Support Medical for...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $51,389.07, is for the delivery of Bydureon Bcise 2 mg autoinjector 0.85 ml, a medication used to treat type 2 diabetes. This is a firm fixed-price delivery order contract with an ultimate completion date of April 27, 2023. The award is not designated as a set-aside contract. AmerisourceBergen Drug...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Bydureon BCISE 2 mg auto-injector, a medication used in the treatment of type 2 diabetes. The contract has a ceiling value of $4,296.62 and an ultimate completion date of May 5, 2023. The contract is a firm fixed-price delivery order, without any set-aside designation,...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,225.46 firm fixed-price contract is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of July 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999...